Investor Presentation MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation Q1FY23
Investor Presentation MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Investor Presentation Q4 & FY22
Investor Presentation MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Please find attached an investors presentation of Marksans Pharma Limited for Q3 & 9M FY22.
Investor Presentation Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Please find attached an investors presentation of Marksans Pharma Limited for Q2 & H1 FY22.
Investor Presentation MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Please find attached an investors presentation of Marksans Pharma Limited for Q1 FY22.
Investor Presentation MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Attached pl find Investors Presentation for the year ended 31st March, 2021
Investor Presentation MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Please find attached an investors presentation of Marksans Pharma Limited for Q3 and 9M FY21.
Investor Presentation MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Please find attached an investors presentation of Marksans Pharma Limited for Q2&H1; FY21.
Investor Presentation MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Investor Presentation BSE India Please find attached an investors presentation of Marksans Pharma Limited for Q1 FY21.
Investor Presentation MARKSANS PHARMA LTD. - 524404 - Investors Presentation BSE India Attached pl find Investors Presentation for the year ended 31st March, 2020